vs
Elme Communities（ELME）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
Elme Communities的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.7倍（$62.1M vs $35.5M），Elme Communities净利率更高（-198.9% vs -304.2%，领先105.4%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs 1.7%），Elme Communities自由现金流更多（$7.2M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 2.7%）
Elme Communities是一家总部位于美国的上市房地产投资信托，主要持有、运营及开发高品质多户住宅项目，业务覆盖美国大西洋中部及东南部核心增长市场，为不同租户群体提供可负担及中档住宅选择。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
ELME vs RXRX — 直观对比
营收规模更大
ELME
是对方的1.7倍
$35.5M
营收增速更快
RXRX
高出680.0%
1.7%
净利率更高
ELME
高出105.4%
-304.2%
自由现金流更多
ELME
多$54.5M
$-47.3M
两年增速更快
RXRX
近两年复合增速
2.7%
损益表 — Q3 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.1M | $35.5M |
| 净利润 | $-123.5M | $-108.1M |
| 毛利率 | 61.1% | 59.8% |
| 营业利润率 | -183.3% | -304.8% |
| 净利率 | -198.9% | -304.2% |
| 营收同比 | 1.7% | 681.7% |
| 净利润同比 | -4058.7% | 39.6% |
| 每股收益（稀释后） | $-1.40 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ELMERXRX
| Q4 25 | — | $35.5M | ||
| Q3 25 | $62.1M | $5.2M | ||
| Q2 25 | $62.1M | $19.2M | ||
| Q1 25 | $61.5M | $14.7M | ||
| Q4 24 | $61.3M | $4.5M | ||
| Q3 24 | $61.1M | $26.1M | ||
| Q2 24 | $60.1M | $14.4M | ||
| Q1 24 | $59.5M | $13.8M |
净利润ELMERXRX
| Q4 25 | — | $-108.1M | ||
| Q3 25 | $-123.5M | $-162.3M | ||
| Q2 25 | $-3.6M | $-171.9M | ||
| Q1 25 | $-4.7M | $-202.5M | ||
| Q4 24 | $-3.0M | $-178.9M | ||
| Q3 24 | $-3.0M | $-95.8M | ||
| Q2 24 | $-3.5M | $-97.5M | ||
| Q1 24 | $-3.6M | $-91.4M |
毛利率ELMERXRX
| Q4 25 | — | 59.8% | ||
| Q3 25 | 61.1% | -183.8% | ||
| Q2 25 | 63.5% | -4.9% | ||
| Q1 25 | 64.2% | -48.0% | ||
| Q4 24 | 62.9% | -181.4% | ||
| Q3 24 | 63.5% | 53.7% | ||
| Q2 24 | 63.4% | 36.2% | ||
| Q1 24 | 63.5% | 19.1% |
营业利润率ELMERXRX
| Q4 25 | — | -304.8% | ||
| Q3 25 | -183.3% | -3327.6% | ||
| Q2 25 | 9.6% | -916.8% | ||
| Q1 25 | 7.8% | -1297.9% | ||
| Q4 24 | 10.4% | -4042.4% | ||
| Q3 24 | 11.0% | -377.1% | ||
| Q2 24 | 9.8% | -697.4% | ||
| Q1 24 | 7.5% | -698.4% |
净利率ELMERXRX
| Q4 25 | — | -304.2% | ||
| Q3 25 | -198.9% | -3135.3% | ||
| Q2 25 | -5.7% | -894.2% | ||
| Q1 25 | -7.6% | -1373.3% | ||
| Q4 24 | -4.9% | -3935.5% | ||
| Q3 24 | -4.9% | -367.5% | ||
| Q2 24 | -5.8% | -676.6% | ||
| Q1 24 | -6.1% | -662.4% |
每股收益（稀释后）ELMERXRX
| Q4 25 | — | $-0.17 | ||
| Q3 25 | $-1.40 | $-0.36 | ||
| Q2 25 | $-0.04 | $-0.41 | ||
| Q1 25 | $-0.05 | $-0.50 | ||
| Q4 24 | $-0.04 | $-0.56 | ||
| Q3 24 | $-0.03 | $-0.34 | ||
| Q2 24 | $-0.04 | $-0.40 | ||
| Q1 24 | $-0.04 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $7.1M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $908.9M | $1.1B |
| 总资产 | $1.7B | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资ELMERXRX
| Q4 25 | — | $743.3M | ||
| Q3 25 | $7.1M | $659.8M | ||
| Q2 25 | $4.8M | $525.1M | ||
| Q1 25 | $6.4M | $500.5M | ||
| Q4 24 | $6.1M | $594.4M | ||
| Q3 24 | $4.8M | $427.6M | ||
| Q2 24 | $5.6M | $474.3M | ||
| Q1 24 | $4.2M | $296.3M |
总债务ELMERXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | — | $11.9M | ||
| Q2 25 | — | $14.2M | ||
| Q1 25 | — | $16.4M | ||
| Q4 24 | — | $19.0M | ||
| Q3 24 | — | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
股东权益ELMERXRX
| Q4 25 | — | $1.1B | ||
| Q3 25 | $908.9M | $1.0B | ||
| Q2 25 | $1.0B | $919.1M | ||
| Q1 25 | $1.1B | $933.9M | ||
| Q4 24 | $1.1B | $1.0B | ||
| Q3 24 | $1.1B | $524.6M | ||
| Q2 24 | $1.1B | $584.4M | ||
| Q1 24 | $1.1B | $401.2M |
总资产ELMERXRX
| Q4 25 | — | $1.5B | ||
| Q3 25 | $1.7B | $1.4B | ||
| Q2 25 | $1.8B | $1.3B | ||
| Q1 25 | $1.8B | $1.3B | ||
| Q4 24 | $1.8B | $1.4B | ||
| Q3 24 | $1.9B | $726.5M | ||
| Q2 24 | $1.9B | $775.9M | ||
| Q1 24 | $1.9B | $557.8M |
负债/权益比ELMERXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | — | 0.01× | ||
| Q2 25 | — | 0.02× | ||
| Q1 25 | — | 0.02× | ||
| Q4 24 | — | 0.02× | ||
| Q3 24 | — | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $15.9M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $7.2M | $-47.3M |
| 自由现金流率自由现金流/营收 | 11.6% | -133.1% |
| 资本支出强度资本支出/营收 | 14.0% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $86.7M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流ELMERXRX
| Q4 25 | — | $-46.1M | ||
| Q3 25 | $15.9M | $-117.4M | ||
| Q2 25 | $29.8M | $-76.4M | ||
| Q1 25 | $16.2M | $-132.0M | ||
| Q4 24 | $95.2M | $-115.4M | ||
| Q3 24 | $20.7M | $-59.2M | ||
| Q2 24 | $28.9M | $-82.2M | ||
| Q1 24 | $21.2M | $-102.3M |
自由现金流ELMERXRX
| Q4 25 | — | $-47.3M | ||
| Q3 25 | $7.2M | $-117.6M | ||
| Q2 25 | $21.1M | $-79.6M | ||
| Q1 25 | $10.5M | $-133.8M | ||
| Q4 24 | $47.9M | $-116.7M | ||
| Q3 24 | $8.8M | $-63.8M | ||
| Q2 24 | $21.0M | $-83.4M | ||
| Q1 24 | $7.6M | $-109.0M |
自由现金流率ELMERXRX
| Q4 25 | — | -133.1% | ||
| Q3 25 | 11.6% | -2272.5% | ||
| Q2 25 | 34.1% | -413.9% | ||
| Q1 25 | 17.1% | -907.4% | ||
| Q4 24 | 78.1% | -2567.7% | ||
| Q3 24 | 14.4% | -244.6% | ||
| Q2 24 | 34.9% | -578.5% | ||
| Q1 24 | 12.8% | -789.9% |
资本支出强度ELMERXRX
| Q4 25 | — | 3.5% | ||
| Q3 25 | 14.0% | 4.7% | ||
| Q2 25 | 14.0% | 16.4% | ||
| Q1 25 | 9.2% | 12.4% | ||
| Q4 24 | 77.4% | 28.6% | ||
| Q3 24 | 19.4% | 17.5% | ||
| Q2 24 | 13.1% | 8.2% | ||
| Q1 24 | 22.9% | 48.2% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ELME
| Residential Segment | $57.7M | 93% |
| Other | $4.4M | 7% |
RXRX
暂无分部数据
